Listar por autor "Rizzetto, M."
Mostrando ítems 1-3 de 3
-
The antiviral response to tenofovir disoproxil fumarate (TDF) is comparable in lamivudine (LAM)-naive and LAM-experienced subjects treated for chronic hepatitis B (CHB)
Manns, M.; Jeffers, L.; Dalekos, G.; Berg, T.; Trepo, C.; Roberts, S.; Prieto, M.; Rizzetto, M.; Sorbel, J.; Anderson, J.; Mondou, E.; Rousseau, F. (2008) -
Long-Term HDV-RNA Suppression - HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy
Niro, G. A.; Smedile, A.; Fontana, R.; Olivero, A.; Ciancio, A.; Pittalunga, F.; Coppola, N.; Wedemeyer, H.; Zachou, K.; Marrone, A.; Fasano, M.; Santantonio, T.; Lotti, G.; Andriulli, A.; Rizzetto, M. (2014) -
SAFETY AND EFFICACY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE THERAPY IN LAMIVUDINE EXPERIENCED PATIENTS
Manns, M.; Jeffers, L.; Dalekos, G.; Berg, T.; Trepo, C.; Roberts, S.; Prieto, M.; Rizzetto, M.; Marcellin, P.; Heathcote, E. J.; Sorbel, J.; Anderson, J.; Mondou, E.; Rousseau, F. (2009)